Struck E, Hagl S, Meisner H, Sebening F
Z Kardiol. 1985;74 Suppl 6:59-63.
The intrinsic limitations of heart transplantation are the restricted availability of donated organs, patient selection, hospitalisation costs, and the limited capacity of cardiac surgery clinics. With a better understanding of organ transplantation and heart transplants in particular, both by the general public and the medical profession, improvements in the care of patients with terminal myocardial disorders seem to be possible with heart transplantation. The one year survival rate for heart transplants is 80%. The success of the treatment is determined by the hemodynamic capacity of the transplanted organ, security against rejection reactions, effects of cellular transplant reactions, and side effects of immunosuppression. Within defined limits heart transplantation is the best standardised method of treatment for terminal myocardial failure.
心脏移植的内在局限性包括捐赠器官的供应有限、患者选择、住院费用以及心脏外科诊所的能力有限。随着公众和医学界对器官移植尤其是心脏移植有了更好的了解，通过心脏移植改善终末期心肌疾病患者的护理似乎是可行的。心脏移植的一年生存率为80%。治疗的成功取决于移植器官的血流动力学能力、抗排斥反应的安全性、细胞移植反应的影响以及免疫抑制的副作用。在规定的范围内，心脏移植是终末期心肌衰竭的最佳标准化治疗方法。
